Management of Cardiovascular Implantable Electronic Devices Infections in High-Risk Patients

Area of Science:

• Cardiology
• Infectious Diseases
• Biomedical Engineering

Background:

• The incidence of cardiovascular implantable electronic device (CIED) infections is increasing, outpacing device implantation rates.
• Rising CIED infection rates are linked to an aging patient population with more comorbidities.
• CIED infections lead to significant morbidity, mortality, healthcare costs, and require complex management, including device explantation.

Purpose of the Study:

• To review the challenges and management of CIED infections.
• To explore risk factors associated with CIED infections.
• To evaluate the potential of antibacterial envelopes in CIED infection prophylaxis.

Main Methods:

• Literature review of CIED infection incidence, risk factors, and management strategies.
• Analysis of existing studies on the efficacy of antibacterial envelopes in preventing CIED infections.
• Mention of an ongoing prospective, randomized trial for further evaluation.

Main Results:

• Numerous host, procedure, and device-related risk factors for CIED infections have been identified.
• Established prevention strategies include intravenous antibiotics and aseptic techniques.
• Several studies indicate a statistically significant reduction in CIED infection incidence with antibacterial envelope use, particularly in high-risk patients.

Conclusions:

• CIED infections represent a substantial health and economic burden requiring critical management.
• Antibacterial envelopes present a promising strategy for reducing CIED infection rates.
• Further evaluation through prospective, randomized trials is warranted to confirm the benefits of antibacterial envelopes.